191 related articles for article (PubMed ID: 24720678)
1. Curing chronic hepatitis C--the arc of a medical triumph.
Chung RT; Baumert TF
N Engl J Med; 2014 Apr; 370(17):1576-8. PubMed ID: 24720678
[No Abstract] [Full Text] [Related]
2. Maria Letizia Barreca on hepatitis C virus treatment and control.
Barreca ML
Future Med Chem; 2016 Jan; 8(1):7-9. PubMed ID: 26689344
[No Abstract] [Full Text] [Related]
3. The Discovery of Hepatitis C - The 2020 Nobel Prize in Physiology or Medicine.
Hoofnagle JH; Feinstone SM
N Engl J Med; 2020 Dec; 383(24):2297-2299. PubMed ID: 33283991
[No Abstract] [Full Text] [Related]
4. [Hepatitis C virus ten years after its discovery].
Bralet MP; Dhumeaux D; Zafrani ES
Ann Pathol; 1999 Dec; 19(6):499-512. PubMed ID: 10617807
[No Abstract] [Full Text] [Related]
5. Enter Sofosbuvir: The Path to Curing HCV.
Sofia MJ
Cell; 2016 Sep; 167(1):25-29. PubMed ID: 27634323
[No Abstract] [Full Text] [Related]
6. Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C.
O'Brien C
J Viral Hepat; 2006 May; 13 Suppl 1():6-14. PubMed ID: 16630042
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus. Preface.
Reddy KR; Kaplan DE
Clin Liver Dis; 2008 Aug; 12(3):xiii-xiv. PubMed ID: 18625424
[No Abstract] [Full Text] [Related]
8. Hepatitis C treatment – yesterday, tomorrow and ….
Weitzel C
Med Monatsschr Pharm; 2017 Apr; 40(4):147-50. PubMed ID: 29952162
[TBL] [Abstract][Full Text] [Related]
9. [Similar poor response in genotype 4 chronic Hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment].
Pérez Mota A; Graus J; García Flores MA; Blanco M; Pérez-Muñoz C; Villalgordo C; Rodero R
Rev Esp Enferm Dig; 2003 Mar; 95(3):238-9. PubMed ID: 12760714
[No Abstract] [Full Text] [Related]
10. Virological relapse in chronic hepatitis C.
Poordad FF; Flamm SL
Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
[TBL] [Abstract][Full Text] [Related]
11. Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients.
Lo Iacono O
Rev Esp Enferm Dig; 2000 Aug; 92(8):485-94. PubMed ID: 11084816
[No Abstract] [Full Text] [Related]
12. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009.
Gelderblom HC; Beld MG
J Clin Virol; 2010 Jun; 48(2):150-1; author reply 152. PubMed ID: 20347385
[No Abstract] [Full Text] [Related]
13. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
Gazdag G; Horvath G; Szabo O; Ungvari GS
Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
[TBL] [Abstract][Full Text] [Related]
14. [Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].
Silva MO; Ridruejo E; Galdame O; Bessone F; Colombato L; Daruich J; Fainboim H; Fassio E; Fay F; Frider B; Gadano A; Galoppo MC; González J; Tanno H; Terg R; Villamil F; ;
Acta Gastroenterol Latinoam; 2012 Sep; 42(3):234-49. PubMed ID: 23214356
[No Abstract] [Full Text] [Related]
15. Pioneering a Global Cure for Chronic Hepatitis C Virus Infection.
Vilarinho S; Lifton RP
Cell; 2016 Sep; 167(1):12-15. PubMed ID: 27634325
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients infected with chronic hepatitis C genotype 2 and 3: more data, more questions?
Graziadei IW; Vogel W
Hepatology; 2009 Feb; 49(2):345-7. PubMed ID: 19177579
[No Abstract] [Full Text] [Related]
17. Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C.
Mihm U; Hofmann WP; Kronenberger B; Wagner Mv; Zeuzem S; Sarrazin C
J Hepatol; 2005 Apr; 42(4):605-6. PubMed ID: 15763349
[No Abstract] [Full Text] [Related]
18. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
Buti M
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
[No Abstract] [Full Text] [Related]
19. Advances in viral hepatitis: 50 years of Australian gastroenterology.
McCaughan G
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S132-5. PubMed ID: 19799691
[TBL] [Abstract][Full Text] [Related]
20. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis.
el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM
Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
